Farxiga for weight loss has become one of the searched diabetes medications for off-label weight management. Its often searched alongside Ozempic, Mounjaro and Trulicity. Patients taking Farxiga for Type 2 diabetes often notice they lose a weight. This is an effect. Patients now ask their doctors about Farxiga for weight loss. This guide explains what Farxiga does. It also explains how weight you can lose what dosage works best and how it compares to Jardiance and Ozempic.
At BodEvolve Bariatric Surgery Center in Texas, Dr. Frenzel and team helps those who are looking for weight loss options like medical weight management programs to gastric sleeve surgery and gastric bypass. These options include medications like Farxiga. They also include injections and surgery.
The truth is, Farxiga does help with weight loss. It’s not a weight loss medication. It requires use to work. This guide gives patients an understanding of Farxigas effectiveness for weight loss.
What Is Farxiga and How Does It Cause Weight Loss?
Farxiga is the brand name for dapagliflozin. It’s a medication made by AstraZeneca. Farxiga is a type of drug called SGLT2 inhibitors.
Farxiga is approved by the FDA for:
- Type 2 diabetes
- Heart failure
- Chronic kidney disease
Farxiga is not approved for:
- Weight loss
- Type 1 diabetes
- People without diabetes who want to lose weight
The medication is taken daily as a 5mg or 10mg tablet.
Weight loss with Farxiga is an effect. It’s not its purpose.
Does Farxiga Cause Weight Loss?
The honest answer is yes. Does Farxiga cause weight loss, it’s modest and not dramatic.
Clinical data shows:
- Average weight loss with Farxiga: 4-6 pounds over 12-24 weeks
- Up to 60-70% of patients experience some weight loss
- Weight loss typically plateaus around the 6-month mark
How Farxiga leads to weight loss:
Farxiga inhibits an enzyme called SGLT2, which is responsible for absorbing glucose back into the blood through urine. This inhibition results in increased glucose excretion in the form of urine, about 70-80 grams each day (280-320 calories).
Calorie expenditure in the form of glucose in urine, along with dehydration, leads to weight loss. Farxiga-induced weight loss differs greatly from that experienced through GLP-1 drugs such as Trulicity, Ozempic, Wegovy, and Victoza, where appetite control and slow food passage are the mechanisms of action.
How Rapid Is Weight Loss with Farxiga?
This is the most common question asked by patients about Farxiga, and the true answer comes down to timing and dosage.
The Farxiga weight loss timeline:
| Time Point | Average Weight Loss |
| Week 1–2 | 1–3 pounds (mostly water weight) |
| Week 4 | 2–4 pounds total |
| Week 8 | 3–5 pounds total |
| Week 12 | 4–6 pounds total |
| Week 24 (6 months) | 5–8 pounds total |
| Week 48 (1 year) | 5–10 pounds total (plateau) |
Straightforward framing of speed:
Farxiga causes one of the slowest rates of weight loss from any off-label diabetes drug for weight loss. Farxiga is less potent than GLP-1 drugs in terms of efficacy.
| Medication | Average Weight Loss at 6 Months |
| Farxiga (dapagliflozin) | 4–6 pounds |
| Jardiance (empagliflozin) | 5–7 pounds |
| Trulicity (dulaglutide) | 8–12 pounds |
| Ozempic (semaglutide) | 12–15 pounds |
| Mounjaro (tirzepatide) | 18–22 pounds |
| Wegovy (semaglutide, higher dose) | 17–20 pounds |
Those patients who expect to experience weight loss through the use of Farxiga may find themselves frustrated. Those patients who suffer from diabetes and experience a 5-8 pound weight loss during their blood glucose management find that this weight loss is an additional benefit of their treatment.
Some initial weight loss will be water weight. The weight loss during the first 5-10 pounds is water weight because the drug makes patients urinate more often.
Average Weight Loss with Farxiga
In studies on the efficacy of Farxiga, the average weight loss has been found to range between 4-6 lbs (2-3% of total body weight).
Factors affecting results include:
- Week 1-2: 1-3 pounds
- Week 4: 2-4 pounds total
- Week 8: 3-5 pounds total
- Week 12: 4-6 pounds total
- Week 24 (6 months): 5-8 pounds total
- Week 48 (1 year): 5-10 pounds total
Farxiga for Weight Loss in Non Diabetics
Commonly asked question:can Farxiga be used for weight loss in non-diabetics? In theory, yes, but with many restrictions.
Problems with the use of Farxiga off-label in non-diabetics:
- Insurance rarely covers it.
- Weight loss results are modest.
- Side effects are the same.
For individuals who are not suffering from diabetes but aim at losing weight through medication, the use of FDA-approved medications such as Wegovy (semaglutide) or Zepbound (tirzepatide) would work effectively compared to using Farxiga, which helps in losing only 2-3% body weight compared to the Semaglutide alternatives which are 12-20% achievable by FDA-approved medications.
Farxiga Weight Loss Reviews: What Patients Actually Experience
Patient experiences regarding Farxiga weight loss reviews share a common trend, both in clinical settings and from patients themselves.
Common experiences shared by patients include:
- 5–10 pounds lost over the first 3–6 months
- Increased urination
- Modest improvement in energy
- No significant appetite changes
- Weight loss plateau at around 6 months for many patients
This pattern matches Trulicity weight loss reviews in one way: patients hoping for dramatic weight loss are typically disappointed while patients prioritizing diabetes or heart failure management often see weight loss as a welcome bonus.
The weight regain pattern is the important honest finding. Studies and clinical experience show that patients who stop Farxiga regain most of the weight within 3-6 months. This is the limitation of medication-based weight loss: the results last only as long as the medication is taken.
Farxiga Weight Loss Before and After
Patients researching Farxiga weight loss before and after should understand the realistic visual expectations:
- Typical 6-month outcomes
- 5–8 pounds total weight loss
- Slight reduction in waist measurement (about 1 inch)
- Minimal change in clothing size for many patients
- More noticeable improvement in blood sugar control than physical appearance
- Improved blood pressure
- Reduced fatigue due to better metabolic control
Farxiga vs Jardiance for Weight Loss
The comparison between Farxiga vs Jardiance for weight loss is very common among patients, because both are SGLT2 inhibitors and their modes of action are alike.
| Feature | Farxiga (dapagliflozin) | Jardiance (empagliflozin) |
| Drug class | SGLT2 inhibitor | SGLT2 inhibitor |
| Manufacturer | AstraZeneca | Boehringer Ingelheim/Eli Lilly |
| Frequency | Once daily | Once daily |
| Doses | 5 mg, 10 mg | 10 mg, 25 mg |
| Average weight loss (6 months) | 4–6 pounds | 5–7 pounds |
| FDA-approved for weight loss | No (off-label) | No (off-label) |
| Cardiovascular benefit | Yes | Yes (slightly stronger evidence) |
| Cost (without insurance) | ~$500–600/month | ~$550–650/month |
Farxiga vs Ozempic for Weight Loss
The Farxiga vs Ozempic for weight loss comparison is one of the common patient questions since both are SGLT2 inhibitors with similar mechanisms.
| Feature | Farxiga | Ozempic |
| Drug class | SGLT2 inhibitor | GLP-1 receptor agonist |
| Mechanism | Urinary glucose excretion | Appetite suppression + slowed digestion |
| Average weight loss (6 months) | 4–6 pounds | 12–15 pounds |
| Frequency | Daily oral tablet | Weekly injection |
| Side effect profile | UTIs, yeast infections, dehydration | Nausea, vomiting, GI issues |
| FDA-approved for weight loss | No | No (Wegovy is the approved version) |
Farxiga and Metformin for Weight Loss
Patients who take Farxiga and metformin together for weight loss will lose around 6-9 pounds compared to Farxiga alone that results in 4-6 pounds of weight loss over a period of 6 months.
Reasons why Farxiga and metformin have a better effect on losing more weight together:
- Metformin limits glucose production in the liver
- Farxiga enhances urinary glucose excretion
- Both processes work via different routes
- Improvement in insulin sensitivity by both drugs
Xigduo XR is the combination of Farxiga and metformin in a one-tablet form to make it easier for patients. Xigduo XR dosing is usually done with Xigduo 5/500 then moved to Xigduo 10/2000 depending upon glucose levels.
True limitation: Despite both Farxiga and metformin, there is just 6-9 pounds of weight loss. That is less than GLP-1 medication and far less than bariatric surgery for Type 2 diabetes, completely in 80-90% of patients and leads to over 100 pounds of weight loss.
Side Effects of Farxiga
Side effects of Farxiga associated with weight loss are caused by the action of the drug and need to be considered beforehand by the patient.
Most frequent side effects:
- Urinary tract infections (UTI)- 4-7% of patients develop because of high glucose in their urine
- Genital thrush infection- especially women (8-10%)
- Polyuria- frequent urination, especially in the first 4-6 weeks of therapy
- Dehydration- patients should keep enough fluids in their body
- Polidipsia
- Vertigo or dizziness
Side Effects That Most Patients Can Handle:
UTIs and yeast infections are possibilities, but can be easily managed through appropriate hygiene and increased fluid intake. Most patients have been able to adjust to Farxiga use after their first 4-6 weeks. Around 8-10 percent of patients quit using Farxiga because of side effects.
Cost of Farxiga for Weight Loss
A high cost of Farxiga treatment for weight loss is a substantial issue for many patients. Costs when paying cash with no insurance coverage: Around $500-600 per month or $6,000-7,200 per year. Cost with insurance for diabetes or heart failure: Around $25-100 per month depending on proper coverage. Costs with insurance for weight loss only: Not covered by any plan that doesn’t have diabetes or heart disease preconditions for taking SGLT2 inhibitors.
Cost reality long term:
The cost of paying cash for 5 years for Farxiga to sustain a moderate weight loss would be around $30,000-36,000, which is much more expensive than getting bariatric surgery without insurance, yet providing 10 times lower results in weight loss.
Costs and results of different weight loss treatments after 5 years:
| Treatment | 5-Year Cost (Cash) | Average Weight Loss |
| Farxiga | $30,000–36,000 | 5–8 pounds |
| Trulicity | $55,000–60,000 | 10–12 pounds |
| Ozempic | $55,000–60,000 | 20–30 pounds |
| Bariatric surgery (one-time) | $15,000–25,000 | 100+ pounds |
Such a cost comparison is one of the most compelling reasons for bariatric surgery: a one-off operation costs far less than 1-2 years of pharmaceuticals and produces 10-20 times as much weight loss.
When Bariatric Surgery Becomes the Better Long-Term Option
For patients with BMI of 35 or above (or BMI of 30 and obesity-associated comorbidities), the cost-effectiveness of choosing Farxiga vs bariatric surgery will be completely different.
5 years of Farxiga usage:
- Weight loss: 5-8 pounds (maximum amount achievable)
- Total costs: $30,000 to $36,000 (self-pay) or $1,500 to $6,000 (with insurance coverage)
- Side effects: Permanent UTIs, recurring yeast infections, increased dehydration risk
- Outcome after discontinuation: Weight gain back within 3 to 6 months
- Elimination of diabetes: 0% — only possible through managing symptoms
- Frequency: Every day for years (and potentially a lifetime)
Bariatric surgery (one-time surgical procedure):
- Weight loss: 60-80% of excess body weight
- Total costs: $15,000 to $25,000 (self-pay), or insurance coverage is often available
- Side effects: Recovery period post-surgery (2-4 weeks)
- Long-term outcome: Physiological change; 60-70% of lost weight
For such patients with a BMI criteria for bariatric surgery (BMI ≥ 35, or BMI ≥ 30 with other co-morbid conditions such as diabetes, sleep apnea, or hypertension), surgery offers long-lasting solutions with significantly greater effectiveness compared to years on medication.
Procedures commonly recommended for such patients include the following:
- Sleeve gastrectomy – removal of about 80% of the stomach; 60-70% of extra weight loss
- Gastric bypass – creation of a small stomach pouch with altered intestinal connections; 70-80% of extra weight loss; resolution of type 2 diabetes in 80-90% of cases
- Duodenal switch and SADI– more drastic approaches for patients with high BMIs
If we are talking about type 2 diabetes, one should note that gastric bypass surgery can resolve the condition in 80-90% of the patients; however, while resolving diabetes in a matter of weeks after the operation, Farxiga is limited to managing the disease without curing it. At BodEvolve, best bariatric surgeon in Texas office, we regularly examine patients using Farxiga before moving on to bariatric surgery.
Talk to a BodEvolve Bariatric Surgeon
Farxiga is one tool in the landscape of weight loss options but it is rarely the most effective choice. Especially for patients facing significant obesity or hoping for meaningful results. The patients who succeed term are typically those who match the right tool to their specific situation: medical management with stronger medications for some, GLP-1 therapy for others and bariatric surgery for those ready for permanent change. For patients exploring weight management with diabetes medications considering gastric sleeve, gastric bypass, duodenal switch or SADI surgery. Or those who want a thorough surgeon-led evaluation of their best path forward. The BodEvolve team is the right starting point.
Patients across Dallas, Arlington, Richardson, Texarkana and surrounding DFW areas can reach out for a consultation. The team has performed, over 14,000 procedures holds an ASMBS Center of Excellence accreditation and is led by Dr. Clayton Frenzel and Dr. Brian L. Holt. Both board-certified surgeons.
Book Your Consultation
